Physician profile
Amy Junus
NPI 1710753785
$979.37
in general payments reported to CMS, 2019-2025
9 companies · $489 in 2025
The $489 reported for 2025 was more than what 76% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $490 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $458.29 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $139.80 | 2025 | Watchman Flx |
| Cardiva Medical, INC. | $91.75 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm |
| Chiesi USA, INC. | $81.28 | 2024-2025 | Kengreal, Cleviprex |
| Teleflex LLC | $59.43 | 2024 | Turnpike, Guideliner |
| Abbott Laboratories | $47.84 | 2024 | Femostop, Aveir |
| Astrazeneca Pharmaceuticals Lp | $39.48 | 2025 | Wainua, Farxiga |
| Medtronic, INC. | $33.57 | 2025 | Corevalve Evolut R |
| Actelion Pharmaceuticals US, INC. | $27.93 | 2025 | Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Junus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.